Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells
Cells · 2024
DOI: 10.3390/cells13181537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Jinhuan Xian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Autophagy, Tumor Escape, Benzylisoquinolines, Melanoma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Science and Technology Plan Project of Guangzhou of China.
Abstract (Originalsprache)
Impaired tumor cell antigen presentation contributes significantly to immune evasion. This study identifies Berbamine hydrochloride (Ber), a compound derived from traditional Chinese medicine, as an effective inhibitor of autophagy that enhances antigen presentation in tumor cells. Ber increases MHC-I-mediated antigen presentation in melanoma cells, improving recognition and elimination by CD8+ T cells. Mutation of Atg4b, which blocks autophagy, also raises MHC-I levels on the cell surface, and further treatment with Ber under these conditions does not increase MHC-I, indicating Ber’s role in blocking autophagy to enhance MHC-I expression. Additionally, Ber treatment leads to the accumulation of autophagosomes, with elevated levels of LC3-II and p62, suggesting a disrupted autophagic flux. Fluorescence staining and co-localization analyses reveal that Ber likely inhibits lysosomal acidification without hindering autophagosome–lysosome fusion. Importantly, Ber treatment suppresses melanoma growth in mice and enhances CD8+ T cell infiltration, supporting its therapeutic potential. Our findings demonstrate that Ber disturbs late-stage autophagic flux through abnormal lysosomal acidification, enhancing MHC-I-mediated antigen presentation and curtailing tumor immune escape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- Department of Pathology and Pathophysiology, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- Department of Biochemistry, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong 999077, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Science and Technology Plan Project of Guangzhou of China
Zitieren
APA
Xian, J., Gao, L., Ren, Z., Jiang, Y., Pan, J., Ying, Z., Guo, Z., Du, Q., Zhao, X., Jin, H., Yi, H., Guan, J., & Hu, S. (2024). Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells. Cells. https://doi.org/10.3390/cells13181537
Vancouver
Xian J, Gao L, Ren Z, Jiang Y, Pan J, Ying Z, et al. Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells. Cells. 2024. doi:10.3390/cells13181537
BibTeX
@article{Xian2024,
author = {Xian, Jinhuan and Gao, Leilei and Ren, Zhenyang and Jiang, Yanjun and Pan, Junjun and Ying, Zheng and Guo, Zhenyuan and Du, Qingsong and Zhao, Xu and Jin, He and Yi, Hua and Guan, Jieying and Hu, Shan},
title = {Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13181537}
}
EUVIMED